@article{oai:soar-ir.repo.nii.ac.jp:00003896,
 author = {Katoh,  Nagaaki and Matsuda,  Masayuki and Ishii,  Wataru and Morita,  Hiroshi and Ikeda,  Shu-ichi},
 issue = {3},
 journal = {INTERNAL MEDICINE},
 month = {},
 note = {We report a patient with stiff-person syndrome and insulin-dependent diabetes mellitus with anti-glutamic acid decarboxylase (GAD) antibody, who suddenly complained of diplopia due to dysthyroid ophthalmopathy. Therapeutic efficacy of plasmapheresis and high-dose intravenous immunoglobulin was transient. After starting administration of rituximab, the patient showed obvious improvement of muscle spasms due to stiff-person syndrome and ophthalmoplegia following quick depletion of CD20-positive cells in peripheral blood. The anti-GAD and anti-thyroid antibodies decreased slowly. This drug might be a potent therapeutic option for refractory patients with stiff-person syndrome, particularly in those associated with dysthyroid ophthalmopathy., Article, INTERNAL MEDICINE. 49(3):237-241 (2010)},
 pages = {237--241},
 title = {Successful Treatment with Rituximab in a Patient with Stiff-Person Syndrome Complicated by Dysthyroid Ophthalmopathy},
 volume = {49},
 year = {2010}
}